Third Quarter Highlights Contract revenues increased 12.0% to $1.272 billion Non-GAAP Adjusted EBITDA increased to $170.7 million, or 13.4% of contract revenues […]
BEDFORD, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused […]